electroCore, Inc (ECOR)

Etorro trading 970x250
electroCore, Inc (ECOR) Logo

About electroCore, Inc

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Rockaway, New Jersey. Address: 200 Forge Way, Rockaway, NJ, United States, 07866

electroCore, Inc News and around…

Latest news about electroCore, Inc (ECOR) common stock and company :

electroCore to Announce Third Quarter 2021 Financial Results on Thursday, November 4th
21 Oct, 2021 Yahoo! Finance

ROCKAWAY, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the third quarter ended September 30, 2021 after the close of the market on Thursday, November 4, 2021. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions. Thursday, November 4, 2021, 4:30pm Eastern TimeDomestic: 877-269-7756International

electroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England
20 Oct, 2021 Yahoo! Finance

ROCKAWAY, NJ, Oct. 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper entitled “Non-invasive vagus nerve stimulation for treatment of cluster headache: a retrospective review of prescribing in England,” in the British Journal of Healthcare Management. The paper reviews the prescribing trends of gammaCore in England from April 2019 through the end of 2020. gammaCore was listed o

electroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine
14 Oct, 2021 Yahoo! Finance

Health Canada expands gammaCore label to include the acute and preventive treatment of migraine in adolescentsROCKAWAY, NJ, Oct. 14, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that the company received an amended Medical Device License from Health Canada to expand the label of gammaCore nVNS to include the acute and preventive treatment of migraine in adolescents between 12 and 17 years of age. gammaCore is now cl

electroCore Provides Business Update and Select Third Quarter 2021 Financial Guidance
12 Oct, 2021 Yahoo! Finance

Third quarter 2021 revenue expected to be approximately $1.5 millionNet cash used to fund operations in the third quarter 2021 of approximately $3.5 million ROCKAWAY, NJ, Oct. 12, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an operating and business update as well as select unaudited preliminary financial guidance for the third quarter of 2021. “We are pleased to announce preliminary third quarter results, which con

electroCore Announces Acceptance of Motion to Dismiss in the Federal Court Securities Class Action Suit
07 Oct, 2021 Yahoo! Finance

ROCKAWAY, NJ, Oct. 07, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced the granting of the company’s motion to dismiss the federal court securities class action case filed in Trenton, NJ. On August 13, 2021, New Jersey Federal District Court Judge Anne E. Thompson dismissed the investors' complaint alleging that statements made in the registration statement for the company’s initial public offering in 2018, and public statem

36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021
04 Oct, 2021 Yahoo! Finance

RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5th \- 8th, 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.The Fall Harvest - Best Ideas from the Buy Side: VIRTUAL begins on Tuesday, October 5th, 2021, with company presentations beginning at 8:30 am Eastern Time.

electroCore Presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference
30 Sep, 2021 FinancialContent
7 Best Penny Stocks to Buy on the Nasdaq for October
29 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks have a place in every portfolio when adjusted for risk. These 7 have the added safety of a Nasdaq listing. The post 7 Best Penny Stocks to Buy on the Nasdaq for October appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients
29 Sep, 2021 FinancialContent
12 Health Care Stocks Moving In Tuesday's After-Market Session
28 Sep, 2021 FinancialContent

Gainers Geovax Labs (NASDAQ:GOVX) shares rose 46.37% to $6.06 during Tuesday's after-market session. This security traded at a ...

12 Health Care Stocks Moving In Friday's After-Market Session
24 Sep, 2021 FinancialContent

Gainers eFFECTOR Therapeutics (NASDAQ:EFTR) stock rose 4.43% to $17.91 during Friday's after-market session. The ...

2 “Strong Buy” Penny Stocks That Are Headed to a Triple-Digit Gain
23 Sep, 2021 Yahoo! Finance

Every investor wants to find the best market returns, and they’ll follow a variety of strategies to get there. One common strategy – and one that offers plenty of promise for investors who don’t mind shouldering the extra risk – is to go after penny stocks. Traditionally seen as stocks priced for just pennies per share, these equities are now defined as those with a share price of $5 or less. For the tough-minded investors, these low-cost stocks present a combination of risk/reward that few othe

electroCore to Participate at Upcoming Investor Conferences
23 Sep, 2021 FinancialContent
electroCore Announces Peter Cuneo as Board Chairman 
20 Sep, 2021 FinancialContent
electroCore Announces Peter Cuneo as Board Chairman
20 Sep, 2021 Yahoo! Finance

ROCKAWAY, NJ, Sept. 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Board of Directors has appointed Peter Cuneo as Chairman of the Board of Directors effective October 1, 2021. Mr. Cuneo was appointed to the Board of Directors in April 2020. He succeeds Mike Atieh, who served as Chairman since April 2020 and who will remain on the Board as an independent director and member of the audit committee. Over th

electroCore Announces New Patent Expanding Claims Related to Delivery of Non-Invasive Vagus Nerve Stimulation Therapy Using Mobile Devices
15 Sep, 2021 FinancialContent
electroCore Announces 510(k) Clearance of gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Paroxysmal Hemicrania and Hemicrania Continua
14 Sep, 2021 FinancialContent
electroCore to Present at the HC Wainwright 23rd Annual Global Investment Conference 
31 Aug, 2021 FinancialContent
electroCore to Present at the HC Wainwright 23rd Annual Global Investment Conference
31 Aug, 2021 Yahoo! Finance

ROCKAWAY, NJ, Aug. 31, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will give a corporate presentation at the HC Wainwright 23rd Annual Global Investment Conference. The conference is taking place virtually from September 13 - 15, 2021. Details for the presentation are as follows: HC Wainwright 23rd Annual Global Investment Conference:Date: Monday, September 13, 2021Time: th

electroCore Announces New Reseller Agreement with Red One Medical Devices, LLC.
24 Aug, 2021 FinancialContent
electroCore (NASDAQ:ECOR) Is In A Good Position To Deliver On Growth Plans
16 Aug, 2021 Yahoo! Finance

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Study of Non-Invasive Vagus Nerve Stimulation (nVNS) Shows Improvement in PTSD Symptoms and Decreased Inflammatory Response to Stress
10 Aug, 2021 FinancialContent
ECOR: Impressive Growth: Invigorating Guidance
09 Aug, 2021 Yahoo! Finance

By John Vandermosten, CFA NASDAQ:ECOR READ THE FULL ECOR RESEARCH REPORT Second Quarter 2021 Financial and Operational Results On August 5, 2021, electroCore Inc. (NASDAQ:ECOR) presented its second quarter 2021 financial and operational results in a press release and Form 10-Q filed with the SEC. A conference call with investors and analysts was held concurrent with the release. Revenues

electroCore Announces Second Quarter 2021 Financial Results
05 Aug, 2021 FinancialContent

Second quarter 2021 net sales of $1.3 million, increased 69% over second quarter 2020 and 5% sequentially. Company to host a conference call and webcast today, August 5, 2021 at 4:30 pm ET

electroCore Announces Publication in PharmacoEconomics Reiterating Economic Benefits of gammaCore for Cluster Headache Outlined by The National Institute for Health and Care Excellence (NICE) Medical
04 Aug, 2021 FinancialContent
electroCore to Present at the Canaccord Genuity Growth Conference
02 Aug, 2021 FinancialContent
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
28 Jul, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! We're halfway through the week and still going strong with a look at the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now.

ElectroCore Analyst: Nerve Stimulation Market Opportunity Is Large
27 Jul, 2021 FinancialContent

A combination of a large total addressable market, regulatory clearance, strong partnershipsand effective product has Ladenburg ...

ElectroCore Stock Is Trading Higher As Ladenburg Initiates Coverage With $3 Price Target, Buy Rating
27 Jul, 2021 FinancialContent

Ladenburg Thalmannhas initiated coverageofElectroCore Inc(NASDAQ: ECOR) with a Buy rating and $3 price ...

electroCore Announces Issuance of New Patent for Migraine Treatment using Smartphones
27 Jul, 2021 FinancialContent

electroCore, Inc (ECOR) is a NASDAQ Common Stock listed in , ,

970x250